SPR Therapeutics Raise $5M For Commercializing Pain Therapies

Written by  Anuja Vaidya | Friday, 18 January 2013 19:42
Social sharing
SPR Therapeutics, a medical device company, has raised $5 million in the initial phase of financing for the commercialization of pain therapies using its proprietary peripheral nerve stimulation technology, according to a peHUB report.   

SPR Therapeutics has developed devices and technologies, such as the Micropulse investigational pain therapy device, to address acute and chronic joint pain disorders. SPR's therapies use a method of peripheral nerve stimulation to treat pain, where electrodes are positions in proximity to but not directly contacting peripheral nerves.

More Articles on Pain Management:

New Pain Management Center Opens in Virginia
Indiana State Senator Drafts Legislation to Restrict Opioid Prescriptions
Prospira PainCare Acquires National Pain Institute

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months